Company & Sponsor Intelligence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials21
Recruiting0
Completed15
Countries5
Therapeutic footprint
bipolar_disorderdepressionepilepsypain_neuropathyptsdschizophrenia
Indexed studies
NCT01387607A Study For Pregabalin In Patients With Fibromyalgia
pain_neuropathy · ChinaPHASE3
pain_neuropathy · ChinaPHASE3
NCT00524030Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
NCT00605865Drug Use Investigation of Jzoloft.
depression · COMPLETED
depression · COMPLETED
NCT01485887Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
depression · JapanPHASE3
depression · JapanPHASE3
NCT00257192Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
schizophrenia · United StatesPHASE3
schizophrenia · United StatesPHASE3
NCT00537238Pregabalin Versus Levetiracetam In Partial Seizures
epilepsy · BelgiumPHASE3
epilepsy · BelgiumPHASE3
NCT01607593A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
ptsd · JapanCOMPLETED
ptsd · JapanCOMPLETED
NCT00596466Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
NCT01474772Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
pain_neuropathy · United StatesPHASE3
pain_neuropathy · United StatesPHASE3
NCT00684424Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
epilepsy · COMPLETED
epilepsy · COMPLETED
NCT00620555A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
epilepsy · JapanPHASE3
epilepsy · JapanPHASE3
NCT01747915A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
epilepsy · United StatesPHASE3
epilepsy · United StatesPHASE3
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →